Reading Time: 6 minutesThe results of the MIROCALS clinical trial into the effects of low dose interleukin-2 (IL-2) on people with MND have now been published in The
Month: May 2025
Reading Time: 5 minutesWith advances in healthcare technologies, more people with MND are now able to live at home supported by equipment such as ventilators and feeding tubes.